Selank

セランク

セランク

セランク, possessing the amino acid sequence H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH, is a potent and long-lasting anti-anxiety drug.

商品コード: 198883 カテゴリー:
愛を分かち合いましょう

セランク, possessing the amino acid sequence H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH, is a potent and long-lasting anti-anxiety drug.

Derived from the retention and subsequent modification of a tuftsin core fragment, this process significantly enhances its ability to cross the 血液脳関門; unique central nervous system activity is a direct result of said modification.

Since the beginning of this century numerous clinical trials have been performed on Selank; complex pharmacological properties spanning multiple modalities and multiple potential targets have been documented.

A stable mechanism of action is what makes Selank particularly valuable; rebound effects do not occur upon discontinuation.

Neurological diseases benefit from a triple regulatory path: 神経伝達物質, neuroplasticity and immune system regulation.

順序

Thr-Lys-Pro-Arg-Pro-Gly-Pro

CAS番号

129954-34-3

分子式

C33H57N11O9

分子量

751.887

Research Of Selank

1.作用機序と治療効果

Its core function is the regulation of the balance within key neurotransmitter systems in the brain.

Modulating the transmission of γ-aminobutyric acid (ギャバ) 具体的には, along with various regulatory effects on serotonin and dopaminergic systems, leads to excellent anti-anxiety and antidepressant effects.

Enhanced hippocampal neuronal plasticity has also been shown; 認知機能の向上 (learning, memory consolidation, attention being prime examples) is at least partially attributable to this line of regulation.

The retention of the original tuftsin core allows for significant efficacy in regulating the cellular immune status, サイトカイン (interferon being one of the better studied) – an immunomodulatory effect the body can use to cope with various stress.

Clinical studies support the improvement of mood and enhanced psychological resilience that Selank facilitates.

2.Anti-anxiety and antidepressant effects

Unlike traditional anti-anxiety and antidepressant drugs, selank does not act directly on GABA receptors.

その代わり, it works by regulating various key neurotransmitters within the brain.

Experiments have shown that selank enhances the transmission efficiency of this inhibitory neurotransmitter, ギャバ; inhibiting excessive neuronal activity and subsequently anxiety being the primary outcome of this process.

Further regulation of neurotransmitters – dopamine being a prime example – allows selank to significantly increase the nervous system’s stress resilience.

Mood swings and associated positive/negative feelings of pleasure are at least partially controlled; 安定した, long term anti-anxiety and antidepressant effects are the result.

Notable side effects (drowsiness, cognitive impairment, addiction being the most well documented) are avoided, making selank a uniquely positioned treatment for certain neurological diseases.

3.Enhancing Cognitive Function and Promoting Neuroplasticity

Selank has demonstrated efficacy in enhancing cognitive function.

Brain Derived Neurotrophic Factor (BDNF) is the focus of much of this research; upregulation of its activity is central to neuronal survival, differentiation and all forms of synaptic plasticity.

Hippocampal cells specifically show increased BDNF related activity when treated with selank.

Neural reorganization through new connections has been observed – memory consolidation, learning ability and attention/concentration all improve.

Clearer thinking, faster information processing and positive results in cognitive tests have all been recorded in patients.

4.Neuroimmune System Regulation

Tuftsin is a natural immune peptide.

Selank retains a core fragment of tuftsin, thus possessing a powerful, though subtle, immunomodulatory effect.

Neuromodulation and this neuro-immune interaction are complementary.

Chronic stress studies show Selank to be particularly well suited to psychological and physiological adaptation.

Improved or at least balanced immune responses contribute to the end result of these mechanisms.

Psychological and physical well-being are interdependent.

5.Potential for treating obsessive-compulsive disorder and agitation

Some reports indicate that selank influences the connection between the 扁桃体 そして 前頭前野; promoting fear extinction being one of the more directly observable effects.

Obsessive-compulsive disorder and various forms of agitation fall under this category as primary targets for treatment.

Animal experiments have shown a significant reduction of agitation-induced fur-puffing behavior, a validated measure of pure agitation.

Scientists have begun to speculate the mechanisms behind this – regulation of at least some aspect of the serotonin system being a leading theory, stress adaptation being enhanced in multiple studies.

Related research is still ongoing, but exploring these potential lines of treatment is important; treating the aforementioned diseases (psychiatric or otherwise) remains a significant and achievable goal.

COA

HPLC

MS

(1) 私たちが欲しいのは, C. R.; 白, C. M. ガンマアミノ酪酸受容体に影響を与える鎮静催眠薬: フルニトラゼパムに注目, ガンマ-ヒドロキシ酪酸, フェニバット, そしてセランク. J クリン ファーマコル 2021, 61 サプリメント 2, S114~S128. 土肥: 10.1002/jcph.1922 From NLM Medline.

(2) かわいそうなこと, A.; コロミン, T.; アンドレーバ, L.; ボンダレンコ, E.; ミャソエドフ, N.; スロミンスキー, P.; シャドリーナ, M. ペプチドセランクは、ラットの予測不可能な慢性軽度ストレス状態における不安を軽減するジアゼパムの効果を増強する. 行動ニューロール 2017, 2017, 5091027. 土肥: 10.1155/2017/5091027 NLM メドラインより.

(3) ピン, L. G.; ナドロワ, あ. V.; アンティポヴァ, T. A.; クルグロフ, S. V.; クドリン, V. S.; ドゥルネフ, あ. D. セランク, タフトシンのペプチド類似体, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med 2019, 167 (5), 641-644. 土肥: 10.1007/s10517-019-04588-9 From NLM Medline.

(4) ピン, L. G.; ナドロワ, あ. V.; セレデニン, S. B. セランクはDBA/2マウスにおけるエタノール誘発性の運動亢進と行動的感作の発現を抑制する. Bull Exp Biol Med 2016, 162 (1), 56-59. 土肥: 10.1007/s10517-016-3544-6 NLM メドラインより.

(5) 料金, N. V.; ソコロフ, O.; ガバエバ, M. V.; グリヴェニコフ, 私. A.; アンドレーバ, L. A.; ミャソエドフ, N. F.; ゾズリア, あ. あ. [Semax と selank はヒト血清のエンケファリン分解酵素を阻害します]]. バイオオルグ・キム 2001, 27 (3), 180-183. 土肥: 10.1023/ある:1011373002885 NLM メドラインより.

(6) わからない, G. G.; テレショバ, E. S.; ボチカレフ, V. K.; コシェレフ, V. V.; シュニャコフ, T. S. P.3.036 新規抗不安薬セランク: 第II相臨床試験の結果. ヨーロッパ神経精神薬理学 2005, 15, S159-S160. 土肥: 10.1016/s0924-977x(05)80332-3.

(7) スロミンスキー, P. A.; シャドリーナ, M. 私。; コロミン, T. A.; スタブロフスカヤ, あ. V.; フィラトヴァ, E. V.; アンドレーバ, L. A.; イラリオシュキン, S. N.; ミャソエドフ, N. F. ペプチド semax と selank は 6-OHDA 誘発性 PD 様パーキンソン病のラットの行動に影響を与える. バイオサイエンスがある限り 2017, 474 (1), 106-109. 土肥: 10.1134/S0012496617030048 From NLM Medline.

(8) ソレルティンスカヤ, T. N.; ショロホフ, M. V.; ミャソエドフ, N. F. さまざまなタイプの神経症における霊長類における Semax と Selank の脳保護効果. 国際精神生理学ジャーナル 2008, 69 (3). 土肥: 10.1016/j.ijpsycho.2008.05.356.

(9) Sollertinskaya, T. N.; Shorokhov, M. V.; Kozlovskaya, M. M.; Kozlovskii, 私. 私。; Sudakov, K. V. Compensatory and antiamnestic effects of heptapeptide Selank in monkeys. Journal of Evolutionary Biochemistry and Physiology 2008, 44 (3), 332-340. 土肥: 10.1134/s0022093008030101.

順序:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

CAS:

129954-34-3

M.W:

751.887 グラム/モル

家 検索 ワッツアップ サービス 製品